Last update 01 Nov 2024

Nhat Nhat Pharmaceutical Co.，Ltd

Private Company|
2017

Overview

Related

2
Drugs associated with Nhat Nhat Pharmaceutical Co.，Ltd
Silibinin
Target
HSP90
Mechanism
HSP90 inhibitors
Active Org.
Augusta UniversityAugusta University [+1]
Originator Org.-
Active Indication
Liver Diseases [+2]
Inactive Indication
Beta-Thalassemia [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.-
First Approval Date-
TONKA
Target-
Mechanism-
Active Org.-
Originator Org.
Nhat Nhat Pharmaceutical Co.，Ltd
Active Indication-
Inactive Indication
liver function failure
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Nhat Nhat Pharmaceutical Co.，Ltd
NCT03216681 / CompletedNot Applicable
An Observational, Open Label, Post Marketing Study to Evaluate the Safety and Effectiveness of Hoat Huyet Nhat Nhat Compared With Gingko Biloba EGb761 (Tanakan 40mg) in Patients With Symptoms Related to the Insufficient Blood Supply to the Brain
NCT03216668 / Unknown statusPhase 3
A Randomized, Active-Control, Open Label, Phase IIIb Study to Evaluate the Safety and Efficacy of TONKA Compared With Silymarin (Legalon) for Lowering Hepatic Enzymes in Liver Function Disorder Patients With Moderate to High Elevated Liver
100 Clinical Results associated with Nhat Nhat Pharmaceutical Co.，Ltd
Login to view more data
0 Patents (Medical) associated with Nhat Nhat Pharmaceutical Co.，Ltd
Login to view more data
100 Deals associated with Nhat Nhat Pharmaceutical Co.，Ltd
Login to view more data
100 Translational Medicine associated with Nhat Nhat Pharmaceutical Co.，Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Silibinin
 ( HSP90 )		liver function failure
More
Pending
TONKA
liver function failure
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free